Treatment of LT-CML stem cells with Metformin28, a known activator of AMPK, increases the phosphorylation of both AMPK and Raptor-Ser792, and phospho-Raptor-Ser792 suppresses mTORC1 activity27. The gene discussed is RPTOR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.